Global Retinal Disease Therapeutics Market Size, Status and Forecast 2020-2026

August 2020 | 96 pages | ID: GE4F55AD23C2EN
QYResearch

Abstracts

This report focuses on the global Retinal Disease Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Retinal Disease Therapeutics development in North America, Europe and Asia-Pacific.

The key players covered in this study

• Merck
• Novartis
• Allergan
• Roche
• Regeneron
• Santen

Market segment by Type, the product can be split into

• Macular Degeneration
• Diabetic Macular Edema
• Diabetic Retinopathy
• Retinal Vein Occlusion

Market segment by Application, split into

• Hospital Pharmacy
• Retail Pharmacy
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Retinal Disease Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Retinal Disease Therapeutics development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Retinal Disease Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Retinal Disease Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Retinal Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Macular Degeneration
  1.4.3 Diabetic Macular Edema
  1.4.4 Diabetic Retinopathy
  1.4.5 Retinal Vein Occlusion
1.5 Market by Application
  1.5.1 Global Retinal Disease Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacy
  1.5.3 Retail Pharmacy
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Retinal Disease Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Retinal Disease Therapeutics Industry
    1.6.1.1 Retinal Disease Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Retinal Disease Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Retinal Disease Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Retinal Disease Therapeutics Market Perspective (2015-2026)
2.2 Retinal Disease Therapeutics Growth Trends by Regions
  2.2.1 Retinal Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Retinal Disease Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Retinal Disease Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Retinal Disease Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Retinal Disease Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Retinal Disease Therapeutics Players by Market Size
  3.1.1 Global Top Retinal Disease Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Retinal Disease Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Retinal Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Retinal Disease Therapeutics Market Concentration Ratio
  3.2.1 Global Retinal Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Retinal Disease Therapeutics Revenue in 2019
3.3 Retinal Disease Therapeutics Key Players Head office and Area Served
3.4 Key Players Retinal Disease Therapeutics Product Solution and Service
3.5 Date of Enter into Retinal Disease Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Retinal Disease Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Retinal Disease Therapeutics Forecasted Market Size by Type (2021-2026)

5 RETINAL DISEASE THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Retinal Disease Therapeutics Market Size by Application (2015-2020)
5.2 Global Retinal Disease Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Retinal Disease Therapeutics Market Size (2015-2020)
6.2 Retinal Disease Therapeutics Key Players in North America (2019-2020)
6.3 North America Retinal Disease Therapeutics Market Size by Type (2015-2020)
6.4 North America Retinal Disease Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Retinal Disease Therapeutics Market Size (2015-2020)
7.2 Retinal Disease Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Retinal Disease Therapeutics Market Size by Type (2015-2020)
7.4 Europe Retinal Disease Therapeutics Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Retinal Disease Therapeutics Market Size (2015-2020)
8.2 Retinal Disease Therapeutics Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Retinal Disease Therapeutics Market Size by Type (2015-2020)
8.4 Asia-Pacific Retinal Disease Therapeutics Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 Merck
  9.1.1 Merck Company Details
  9.1.2 Merck Business Overview and Its Total Revenue
  9.1.3 Merck Retinal Disease Therapeutics Introduction
  9.1.4 Merck Revenue in Retinal Disease Therapeutics Business (2015-2020))
  9.1.5 Merck Recent Development
9.2 Novartis
  9.2.1 Novartis Company Details
  9.2.2 Novartis Business Overview and Its Total Revenue
  9.2.3 Novartis Retinal Disease Therapeutics Introduction
  9.2.4 Novartis Revenue in Retinal Disease Therapeutics Business (2015-2020)
  9.2.5 Novartis Recent Development
9.3 Allergan
  9.3.1 Allergan Company Details
  9.3.2 Allergan Business Overview and Its Total Revenue
  9.3.3 Allergan Retinal Disease Therapeutics Introduction
  9.3.4 Allergan Revenue in Retinal Disease Therapeutics Business (2015-2020)
  9.3.5 Allergan Recent Development
9.4 Roche
  9.4.1 Roche Company Details
  9.4.2 Roche Business Overview and Its Total Revenue
  9.4.3 Roche Retinal Disease Therapeutics Introduction
  9.4.4 Roche Revenue in Retinal Disease Therapeutics Business (2015-2020)
  9.4.5 Roche Recent Development
9.5 Regeneron
  9.5.1 Regeneron Company Details
  9.5.2 Regeneron Business Overview and Its Total Revenue
  9.5.3 Regeneron Retinal Disease Therapeutics Introduction
  9.5.4 Regeneron Revenue in Retinal Disease Therapeutics Business (2015-2020)
  9.5.5 Regeneron Recent Development
9.6 Santen
  9.6.1 Santen Company Details
  9.6.2 Santen Business Overview and Its Total Revenue
  9.6.3 Santen Retinal Disease Therapeutics Introduction
  9.6.4 Santen Revenue in Retinal Disease Therapeutics Business (2015-2020)
  9.6.5 Santen Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Retinal Disease Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Retinal Disease Therapeutics Revenue
Table 3. Ranking of Global Top Retinal Disease Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Retinal Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Macular Degeneration
Table 6. Key Players of Diabetic Macular Edema
Table 7. Key Players of Diabetic Retinopathy
Table 8. Key Players of Retinal Vein Occlusion
Table 9. COVID-19 Impact Global Market: (Four Retinal Disease Therapeutics Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Retinal Disease Therapeutics Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Retinal Disease Therapeutics Players to Combat Covid-19 Impact
Table 14. Global Retinal Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Retinal Disease Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Retinal Disease Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Retinal Disease Therapeutics Market Share by Regions (2015-2020)
Table 18. Global Retinal Disease Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Retinal Disease Therapeutics Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Retinal Disease Therapeutics Market Growth Strategy
Table 24. Main Points Interviewed from Key Retinal Disease Therapeutics Players
Table 25. Global Retinal Disease Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 26. Global Retinal Disease Therapeutics Market Share by Players (2015-2020)
Table 27. Global Top Retinal Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Disease Therapeutics as of 2019)
Table 28. Global Retinal Disease Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Retinal Disease Therapeutics Product Solution and Service
Table 31. Date of Enter into Retinal Disease Therapeutics Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Retinal Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 34. Global Retinal Disease Therapeutics Market Size Share by Type (2015-2020)
Table 35. Global Retinal Disease Therapeutics Revenue Market Share by Type (2021-2026)
Table 36. Global Retinal Disease Therapeutics Market Size Share by Application (2015-2020)
Table 37. Global Retinal Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. Global Retinal Disease Therapeutics Market Size Share by Application (2021-2026)
Table 39. North America Key Players Retinal Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Retinal Disease Therapeutics Market Share (2019-2020)
Table 41. North America Retinal Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. North America Retinal Disease Therapeutics Market Share by Type (2015-2020)
Table 43. North America Retinal Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. North America Retinal Disease Therapeutics Market Share by Application (2015-2020)
Table 45. Europe Key Players Retinal Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Retinal Disease Therapeutics Market Share (2019-2020)
Table 47. Europe Retinal Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Retinal Disease Therapeutics Market Share by Type (2015-2020)
Table 49. Europe Retinal Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Retinal Disease Therapeutics Market Share by Application (2015-2020)
Table 51. Asia-Pacific Key Players Retinal Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 52. Asia-Pacific Key Players Retinal Disease Therapeutics Market Share (2019-2020)
Table 53. Asia-Pacific Retinal Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. Asia-Pacific Retinal Disease Therapeutics Market Share by Type (2015-2020)
Table 55. Asia-Pacific Retinal Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. Asia-Pacific Retinal Disease Therapeutics Market Share by Application (2015-2020)
Table 57. Merck Company Details
Table 58. Merck Business Overview
Table 59. Merck Product
Table 60. Merck Revenue in Retinal Disease Therapeutics Business (2015-2020) (Million US$)
Table 61. Merck Recent Development
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Product
Table 65. Novartis Revenue in Retinal Disease Therapeutics Business (2015-2020) (Million US$)
Table 66. Novartis Recent Development
Table 67. Allergan Company Details
Table 68. Allergan Business Overview
Table 69. Allergan Product
Table 70. Allergan Revenue in Retinal Disease Therapeutics Business (2015-2020) (Million US$)
Table 71. Allergan Recent Development
Table 72. Roche Company Details
Table 73. Roche Business Overview
Table 74. Roche Product
Table 75. Roche Revenue in Retinal Disease Therapeutics Business (2015-2020) (Million US$)
Table 76. Roche Recent Development
Table 77. Regeneron Company Details
Table 78. Regeneron Business Overview
Table 79. Regeneron Product
Table 80. Regeneron Revenue in Retinal Disease Therapeutics Business (2015-2020) (Million US$)
Table 81. Regeneron Recent Development
Table 82. Santen Company Details
Table 83. Santen Business Overview
Table 84. Santen Product
Table 85. Santen Revenue in Retinal Disease Therapeutics Business (2015-2020) (Million US$)
Table 86. Santen Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Retinal Disease Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Macular Degeneration Features
Figure 3. Diabetic Macular Edema Features
Figure 4. Diabetic Retinopathy Features
Figure 5. Retinal Vein Occlusion Features
Figure 6. Global Retinal Disease Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Others Case Studies
Figure 10. Retinal Disease Therapeutics Report Years Considered
Figure 11. Global Retinal Disease Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Retinal Disease Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Retinal Disease Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Retinal Disease Therapeutics Market Share by Players in 2019
Figure 16. Global Top Retinal Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Disease Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Retinal Disease Therapeutics Revenue in 2019
Figure 18. North America Retinal Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Retinal Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Asia-Pacific Retinal Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 22. Merck Revenue Growth Rate in Retinal Disease Therapeutics Business (2015-2020)
Figure 23. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Novartis Revenue Growth Rate in Retinal Disease Therapeutics Business (2015-2020)
Figure 25. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Allergan Revenue Growth Rate in Retinal Disease Therapeutics Business (2015-2020)
Figure 27. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Roche Revenue Growth Rate in Retinal Disease Therapeutics Business (2015-2020)
Figure 29. Regeneron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Regeneron Revenue Growth Rate in Retinal Disease Therapeutics Business (2015-2020)
Figure 31. Santen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Santen Revenue Growth Rate in Retinal Disease Therapeutics Business (2015-2020)
Figure 33. Bottom-up and Top-down Approaches for This Report
Figure 34. Data Triangulation
Figure 35. Key Executives Interviewed